Vimarsana
Biggest News Aggregation in the World

Connien Hess News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Connien Hess. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Connien Hess Today - Breaking & Trending Today

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies - Vimarsana News

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Angioplasty Finally Proven Beneficial in Stable Angina - Vimarsana News

Angioplasty Finally Proven Beneficial in Stable Angina

The randomized ORBITA-2 trial, unlike the preceding ORBITA trial, shows benefit for percutaneous coronary intervention in patients with stable angina.

Angioplasty Finally Proven Beneficial in Stable Angina - Vimarsana News

Angioplasty Finally Proven Beneficial in Stable Angina

The randomized ORBITA-2 trial, unlike the preceding ORBITA trial, shows benefit for percutaneous coronary intervention in patients with stable angina.

Only Half of Revascularized PAD Patients Receive GDMT - Vimarsana News

Only Half of Revascularized PAD Patients Receive GDMT

Lack of clear evidence that it has limb-saving benefits may be part of the problem, say Connie Hess and Marc Bonaca.

Source: tctmd.com
Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients - Vimarsana News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

The secondary analysis from VOYAGER PAD adds reassurance on top of similar data from COMPASS, says Geoffrey Barnes.

Source: tctmd.com